The fourth and last article on Inhalation Biopharmaceutics Classification System, iBCS, by Dr Per Bäckman and colleagues has now been published. By classifying inhaled drugs based on dose, solubility, and permeability, iBCS serves as a valuable tool for formulation scientists to predict drug performance and mitigate development risks. Read the full article here.